HCV infection promotes insulin resistance, mainly through increased tumor necrosis factor α (TNF-α), which inhibit insulin receptor and IRS-1 (insulin receptor substrate) tyrosine phosphorylation [34], [35]. The gene discussed is IRS1; the disease is Insulin resistance.